Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / PHARMACEUTICALS
-
Total 13F shares
-
901,505
-
Share change
-
+126,725
-
Total reported value
-
$69,821,385
-
Price per share
-
$77.37
-
Number of holders
-
91
-
Value change
-
+$9,766,515
-
Number of buys
-
36
-
Number of sells
-
25
Institutional Holders of INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) as of Q3 2021
As of 30 Sep 2021,
INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) was held by
91 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
901,505 shares.
The largest 10 holders included
Peak Asset Management, LLC, WELLINGTON MANAGEMENT GROUP LLP, UBS Group AG, LPL Financial LLC, BANK OF AMERICA CORP /DE/, GOLDMAN SACHS GROUP INC, MORGAN STANLEY, Federation des caisses Desjardins du Quebec, WELLS FARGO & COMPANY/MN, and U.S. Capital Wealth Advisors, LLC.
This page lists
92
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.